MLECP1

Across TCGA pan-cancer cohorts, MLECP1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MLECP1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MLECP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MLECP1 expression acts as an unfavorable survival marker.

UCEC, BRCA, and LIHC are the cancer types where MLECP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.534	0.845	<.001	36	view →
BRCA	DFS	Tertile	All	0.706	0.904	.004	24	view →
LIHC	DFS	Tertile	II,III,IV	0.080	0.427	.019	18	view →
LAML	DFS	Tertile	All	0.309	0.527	.026	12	view →
STAD	OS	Tertile	II,III,IV	0.149	0.565	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MLECP1–UCEC (DFS)

Open the UCEC breakdown →